You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nicotine-dependence in overweight and obese subjects

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Overweight or Obesity Trial (HRS9531 injection, HRS9531 injection Placebo)

Not yet recruiting
  • Overweight or Obesity
  • HRS9531 injection
  • HRS9531 injection Placebo
  • (no location specified)
Sep 19, 2023

Obese, Overweight, Healthy Trial in Chula Vista (LB64640, Placebo)

Completed
  • Obese
  • +2 more
  • Chula Vista, California
    Clinical Research Unit
Sep 13, 2023

Developmental Endothelial Locus-1, Platelet Count, and Soluble

Not yet recruiting
  • Overweight and Obesity
  • Platelet count
  • +2 more
  • Aswan, Egypt
    Aswan University Hospital
May 17, 2023

Overweight Subjects, Obese Subjects Trial in Beijing (metformin, digoxin, IBI362)

Not yet recruiting
  • Overweight Subjects
  • Obese Subjects
  • Beijing, Beijing, China
    Aerospace Center Hospital
Apr 4, 2023

Cystic Fibrosis-related Diabetes, Cystic Fibrosis Trial in Minneapolis (Empagliflozin, Placebo Control)

Not yet recruiting
  • Cystic Fibrosis-related Diabetes
  • Cystic Fibrosis
  • Minneapolis, Minnesota
    University of Minnesota
Nov 20, 2023

Overweight and Obesity Trial in Harbin (HS-20094, Placebo)

Recruiting
  • Overweight and Obesity
  • Harbin, Heilongjiang, China
  • +1 more
Nov 3, 2023

Diabete Type 2, Obesity Trial in Orlando (HU6)

Not yet recruiting
  • Diabete Type 2
  • Obesity
  • Orlando, Florida
    AdventHealth Translational Research Institute
Oct 23, 2023

Overweight or Obesity Trial in United States (GSBR-1290, Placebo)

Recruiting
  • Overweight or Obesity
  • Anaheim, California
  • +3 more
Feb 28, 2023

Body Weight in the Overweight and Obese Class - I Population Trial in Gandhi Nagar (Phaseolean (White Kidney Bean Standardized

Not yet recruiting
  • Body Weight in the Overweight and Obese Class - I Population
  • Phaseolean (White Kidney Bean Standardized Extract) 1500 mg Capsules
  • +2 more
  • Gandhi Nagar, Gujarat, India
    NovoBliss Research Pvt Ltd
Jan 25, 2023

Overweight or Obesity Trial (HRS9531 injection, HRS9531 injection Placebo)

Not yet recruiting
  • Overweight or Obesity
  • HRS9531 injection
  • HRS9531 injection Placebo
  • (no location specified)
May 29, 2023

Healthy Participants Trial in Glendale, Brooklyn (AZD6234, Placebo, Acetaminophen)

Not yet recruiting
  • Healthy Participants
  • Glendale, California
  • +1 more
Aug 19, 2022

Type 2 Diabetes Trial (ALT-801, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • Fort Myers, Florida
  • +6 more
Oct 11, 2022

Metabolic Syndrome Trial in Banja Luka (Polyphenols of pomegranate fruit peel extract (PoPex), Placebo)

Active, not recruiting
  • Metabolic Syndrome
  • Polyphenols of pomegranate fruit peel extract (PoPex)
  • Placebo
  • Banja Luka, Republic Of Srpska, Bosnia and Herzegovina
    Public Health Institution Dom zdravlja Banja Luka
Jun 13, 2023

Overweight and Obesity, Cardiovascular Diseases, Metabolic Syndrome Trial in Bari

Not yet recruiting
  • Overweight and Obesity
  • +3 more
    • Bari, BA, Italy
      Department of Biomedical Sciences and Human Oncology - Clinica m
    Jul 1, 2022

    Cystic Fibrosis, Cystic Fibrosis-related Diabetes Trial in Minneapolis (Semaglutide)

    Not yet recruiting
    • Cystic Fibrosis
    • Cystic Fibrosis-related Diabetes
    • Minneapolis, Minnesota
      University of Minnesota
    Mar 15, 2023

    Overweight and Obesity Trial in Florence (Dietary intervention - intervention group, Dietary intervention - control group)

    Recruiting
    • Overweight and Obesity
    • Dietary intervention - intervention group
    • Dietary intervention - control group
    • Florence, Italy
      Unit of Clinical Nutrition, University Hospital of Careggi
    Jul 4, 2023

    Overweight and Obesity, PreDiabetes, Type2 Diabetes Trial in Frederiksberg (Gelesis200, Placebo, Gelesis200 and Placebo)

    Completed
    • Overweight and Obesity
    • +2 more
    • Gelesis200
    • +2 more
    • Frederiksberg, Denmark
      University of Copenhagan
    Apr 1, 2022

    Weight Loss Trial in Pavia (Polyglucosamine L112, Placebo)

    Enrolling by invitation
    • Weight Loss
    • Polyglucosamine L112
    • Placebo
    • Pavia, Lombardia, Italy
      Azienda di Servizi alla Persona Istituzioni Assistenziali Riunit
    Mar 12, 2022

    Nonalcoholic Steatohepatitis (NASH), Overweight or Obesity Trial in Chula Vista, Montclair (FT-4101, FT-4101 , Deuterated Water)

    Terminated
    • Nonalcoholic Steatohepatitis (NASH)
    • Overweight or Obesity
    • Chula Vista, California
    • +1 more
    Mar 14, 2022

    Overweight and Obesity, Type2 Diabetes, NAFLD Trial in Puerto Rico, United States (DD01, Placebo)

    Recruiting
    • Overweight and Obesity
    • +2 more
    • Chula Vista, California
    • +3 more
    May 3, 2022

    Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)

    Active, not recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Montclair, California
    • +12 more
    Oct 11, 2022

    Overweight and Obese Subjects

    Completed
    • Prediabetes
      • Neuss, Germany
        Profil Institut für Stoffwechselforschung GmbH
      Dec 28, 2021

      Overweight or Obesity Trial in Hlohovec (IMD SiPore21®)

      Recruiting
      • Overweight or Obesity
      • IMD SiPore21®
      • Hlohovec, Slovakia
        Diversitas s.r.o., SNP 870/10
      Oct 23, 2023

      Diabetes Trial in Guangzhou, Nanjing (Experimental: Cotadutide, Placebo)

      Recruiting
      • Diabetes
      • Experimental: Cotadutide
      • Placebo
      • Guangzhou, China
      • +1 more
      Jul 21, 2022

      Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)

      Active, not recruiting
      • Non-Alcoholic Fatty Liver Disease
      • Scottsdale, Arizona
      • +14 more
      Jun 30, 2022